Expression of a novel CNPY2 isoform in colorectal cancer and its association with oncologic prognosis-Reference-Cited by-同舟云学术

Expression of a novel CNPY2 isoform in colorectal cancer and its association with oncologic prognosis

Published:2017-11-13 Issue:11 Volume:9 Page:2334-2351
ISSN:1945-4589
Container-title:Aging
language:en
Short-container-title:Aging

Author:

Peng Jianhong¹,Ou Qingjian¹²,Guo Jian³,Pan Zhizhong¹,Zhang Rongxin¹,Wu Xiaojun¹,Zhao Yujie¹,Deng Yuxiang¹,Li Caixia⁴,Wang Fulong¹,Li Liren¹,Chen Gong¹,Lu Zhenhai¹,Ding Peirong¹,Wan Desen¹,Fang Yujing¹²

Affiliation:

1. Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong 510060, P. R. China

2. Department of Experimental Research, Sun Yat-sen University Cancer Center; State Key Laboratory of Oncology in South China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong 510060, P. R. China

3. Senboll Biotechnology Co., Ltd., Pingshan Bio-pharmacy Business Accelerator Unit 205, Shenzhen, Guangdong 518000, P. R. China

4. School of Mathematics and Computational Science, Sun Yat-sen University, Guangzhou, Guangdong, P. R. China

Publisher

Impact Journals, LLC

Subject

Cell Biology,Aging

Cited by 12 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. MCT4 is an independent prognostic factor and affects immune cell infiltration in patients with colorectal liver oligometastases;Clinical and Translational Oncology;2024-09-13

2. Progress in Research on CNPY2 in Diseases;Mini-Reviews in Medicinal Chemistry;2024-03

3. MicroRNA-30e-3p inhibits glioma development and promotes drug sensitivity to temozolomide treatment via targeting canopy FGF signaling regulator 2;Cell Cycle;2021-10-17

4. Canopy Fibroblast Growth Factor Signaling Regulator 2 (CNPY2) Inhibits Neuron Apoptosis in Parkinson’s Disease via the AKT/GSK3β Pathway;Current Neurovascular Research;2021-08-11

5. Canopy Homolog 2 as a Novel Molecular Target in Hepatocarcinogenesis;Cancers;2021-07-19